UroToday.com - A report in the December, 2007 issue of Urology by M.J. Lange and associates links androgen-deprivation therapy (ADT) for prostate cancer (CaP) to incident diabetes mellitus (DM). The study rationale is based upon knowledge that ADT is associated with loss of lean body mass, increase of fat body mass, hyperglycemia, and insulin resistance. An administrative claims database was used to identify men having CaP between 2000 and 2005.